Related Experiment Video
Updated: Jul 7, 2025
07:34
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
694
Reliability of Systematic and Targeted Biopsies versus Prostatectomy
Tianyuan Guan1, Abhinav Sidana2, Marepalli B Rao3
1College of Public Health, Kent State University, Kent, OH 44240, USA.
Bioengineering (Basel, Switzerland)
|December 23, 2023
Summary
Systematic biopsy (SBx) and MRI-guided biopsy (MRITBx) show fair agreement with prostatectomy for prostate cancer detection. MRITBx offers slightly higher accuracy, and new biomarkers aim to further improve diagnostic precision.
Area of Science:
- Urology
- Oncology
- Medical Imaging
Background:
- Prostate cancer detection relies on systematic biopsy (SBx), with MRI-guided biopsy (MRITBx) offering potential improvements.
- Prostatectomy provides definitive pathological assessment, serving as a benchmark for biopsy accuracy.
Purpose of the Study:
- To evaluate the reliability of SBx and MRITBx against prostatectomy findings using Gleason scores.
- To compare the diagnostic accuracy of SBx and MRITBx in detecting prostate cancer.
Main Methods:
- Comparative analysis using Cohen's Kappa index and logistic regression on binarized Gleason scores.
- Application of machine learning, specifically classification trees, for enhanced prediction.
Main Results:
- Cohen's Kappa indicated fair agreement for both SBx (0.31) and MRITBx (0.34) versus prostatectomy.
- SBx showed 83% sensitivity and 50% specificity; MRITBx demonstrated 78% sensitivity and 67% specificity compared to prostatectomy.
- MRITBx exhibited a higher accuracy level than SBx in this comparison.
Conclusions:
- While SBx and MRITBx do not fully replicate prostatectomy results, they remain valuable diagnostic tools.
- Development of novel biomarkers and prediction models using classification trees can improve the accuracy of prostate cancer grading.
